Sector dividends Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
21:00:02 14/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 280.05 USD | -0.43% |
|
+4.70% | +40.39% |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | 74.93x | 4.44x | 3.96x | 15.35x | 18.86x | 13.37B | ||
| 0.97% | 1.12% | 33.04x | 4.4x | 5.91x | 17.56x | 24.7x | 48.42B | ||
| -.--% | -.--% | -21.14x | 22.11x | 288.75x | -21.43x | -20.64x | 43.66B | ||
| -.--% | -.--% | 45.52x | 7.71x | 5.25x | 28.69x | 33.16x | 39.51B | ||
| -.--% | -.--% | 30.48x | 5.57x | 3.03x | 13.08x | 19.76x | 38.95B | ||
| 0.38% | 0.41% | 30.58x | 2.49x | 8.82x | 22.17x | 26.41x | 32.61B | ||
| -.--% | -.--% | 32.9x | 23.6x | 5.38x | 24.45x | 25.58x | 16.15B | ||
| 1.15% | 1.3% | 23.48x | 2.63x | 2.05x | 8.89x | 13.76x | 14.16B | ||
| -.--% | -.--% | 27.64x | 1.31x | 1.83x | 11.26x | 12.82x | 12.59B | ||
| 0.49% | 0.59% | 46.54x | 5.04x | 5.27x | 22.16x | 35x | 12.12B | ||
| 0.44% | 0.44% | 60.84x | 5.2x | 9.27x | 26.36x | 28.8x | 11.28B | ||
| -.--% | -.--% | -28.96x | 8.52x | 103.44x | -29.45x | -51.24x | 10.25B | ||
| -.--% | -.--% | -26.41x | 9.12x | 11054.5x | -21.83x | -21.5x | 10.24B | ||
| -.--% | -.--% | -28.86x | 9.26x | - | -25.48x | -25.54x | 10.15B | ||
| -.--% | -.--% | 33.49x | - | 17.53x | 32.54x | 31.6x | 10.04B | ||
| -.--% | -.--% | -30.48x | 8.81x | 79.66x | -20.25x | -19.71x | 9.76B | ||
| -.--% | -.--% | -16.02x | 662.65x | 10.22x | -16.51x | -15.95x | 9.51B | ||
| -.--% | -.--% | -36.52x | 19.11x | 6.22x | 152.24x | -2025.71x | 9.4B | ||
| 0.6% | 0.74% | 20.58x | 2.37x | 4.42x | 11.79x | 15.03x | 8.88B | ||
| Average | 0.21% | 0.24% | 14.30x | 44.69x | 645.31x | 13.24x | -99.73x | 19B | |
| Weighted average by Cap. | 0.25% | 0.29% | 19.36x | 26.38x | 368.46x | 12.29x | -41.37x |
Select your edition
All financial news and data tailored to specific country editions
















